Tranzyme Pharma's Series B Round

Tranzyme Pharma raised a round of funding on December 23, 2002.

Tranzyme is a biopharmaceutical company developing small molecule therapeutics for the treatment of gastrointestinal and metabolic disorders.…

Articles about Tranzyme Pharma's Series B Round: